10-QPeriod: Q1 FY2026

CME GROUP INC. Quarterly Report for Q1 Ended Mar 31, 2026

Filed April 24, 2026For Securities:CME

Summary

CME Group Inc. reported strong financial results for the first quarter of 2026, with total revenues increasing by 14% year-over-year to $1.88 billion. This growth was primarily driven by a significant 15% increase in clearing and transaction fees, fueled by a 22% rise in contract volume. The company benefited from heightened market volatility across various asset classes, including interest rates, energy, and metals, largely attributed to ongoing geopolitical conflicts and resultant economic uncertainty. Despite an increase in operating expenses by 7% to $570.4 million, driven by higher compensation, technology, and licensing costs, CME Group maintained a robust operating margin of 69.7%. Net income saw a substantial 21% increase to $1.15 billion, resulting in diluted earnings per share of $3.18, also up 21%. The company's liquidity remains strong, with $2.4 billion in cash and cash equivalents (excluding restricted cash) and significant borrowing capacity available. CME Group also continued its share repurchase program, having repurchased approximately $539 million of its Class A common stock during the quarter.

Financial Statements
Beta
Revenue$1.88B
Operating Expenses$570.40M
Operating Income$1.31B
Net Income$1.15B
EPS (Basic)$3.25
EPS (Diluted)$3.18
Shares Outstanding (Basic)359.32M
Shares Outstanding (Diluted)363.21M

Key Highlights

  • 1Total revenues grew 14% to $1.88 billion in Q1 2026 compared to Q1 2025.
  • 2Clearing and transaction fees increased by 15% to $1.54 billion, driven by a 22% surge in total contract volume.
  • 3Net income rose 21% to $1.15 billion, with diluted EPS increasing to $3.18.
  • 4Market volatility, attributed to geopolitical events, boosted volume across interest rates, energy, and metals.
  • 5Operating expenses increased 7% to $570.4 million, primarily due to higher compensation, technology, and licensing costs.
  • 6The company repurchased approximately $539 million of its Class A common stock during the quarter under its $3.0 billion share repurchase program.
  • 7Strong liquidity position maintained, with $2.4 billion in cash and cash equivalents (excluding restricted cash).

Frequently Asked Questions

CME Group's revenue increased by 14% to $1.88 billion primarily due to a 15% rise in clearing and transaction fees. This growth was driven by a substantial 22% increase in total contract volume, which was itself spurred by heightened market volatility across various asset classes like interest rates, energy, and metals, influenced by geopolitical events.

Operating expenses increased by 7% to $570.4 million. The primary drivers for this increase included higher compensation and benefits costs due to salary increases and headcount growth, increased technology support services for the Google Cloud transformation, and higher licensing fees related to new and high-volume equity products. Employee separation and restructuring costs also contributed to the rise.

CME Group demonstrated strong financial health with a 21% increase in net income to $1.15 billion and a healthy operating margin of 69.7%. Liquidity remains robust, with $2.4 billion in cash and cash equivalents (excluding restricted cash) and substantial available borrowing capacity under its credit facilities. The company also actively returned capital to shareholders through its share repurchase program.

The ongoing geopolitical conflict has been a significant factor contributing to increased market volatility. This volatility has led to higher trading volumes across CME Group's product lines, particularly in interest rates, energy, metals, and some equity index products, as market participants seek to manage risk and capitalize on price movements. This increased volume has directly benefited CME Group's revenue.